Evidence
Aust N Z J Psychiatry. 2023 Dec 21:48674231209840. doi: 10.1177/00048674231209840. Online ahead of print.
ABSTRACT
The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
PMID:38130026 | DOI:10.1177/00048674231209840
Add to Google Keep
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
🌐 90 Days
VR Related Evidence Matrix
- HIV Viral Suppression Among Psychiatric Inpatients with Schizophrenia in San Francisco: A Retrospective Cohort Study
- A lifetime of mental health treatments for people with schizophrenia: update and narrative review
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- The contribution of first-episode illness characteristics and cumulative antipsychotic usage to progressive structural brain changes over a long-term follow-up in schizophrenia
- Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial
- Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study
- Research Letter: Perceived rather than actual reduction in standard of living is associated with psychological distress: A cross-sectional survey of working Australians
- Psychotic Experiences and Daily Functioning in Borderline Personality Disorder and Schizophrenia
- Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
- D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up
- Schizophrenia in Autistic People with Intellectual Disabilities. Treatment and Interventions
- Luxenburger's 1939 Essay on "Schizophrenia and its Hereditary Circle"
- Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report
- A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
- Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
- Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia
- Career progression for autistic people: A scoping review
- Orphan GPR52 as an emerging neurotherapeutic target
- Longitudinal association of social isolation and loneliness with physical function among in-patients living with schizophrenia
- Modulation of mGlu5 reduces rewarding associative properties of nicotine via changes in mesolimbic plasticity: Relevance to comorbid cigarette smoking in psychosis
- Mirtazapine Monotherapy for Antipsychotics-refractory Psychosis in a Patient with Very-late-onset Schizophrenia-like Psychosis: A Case Report
- Average lifespan variation among people with mental disorders in Denmark: a nationwide, register-based cohort study
- Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder
- Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series
- The identification of novel schizophrenia-related metabolites using untargeted lipidomics
- Importance of Capgras syndrome in shared psychotic disorder: a case report
- Cognitive Control in Schizophrenia: Advances in Computational Approaches
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Maternity in women with schizophrenia and schizoaffective disorder
- Suicide attempts in schizophrenia - A large retrospective cohort study from a tertiary care psychiatry centre in India
- Are thoughts and behaviours of individuals with schizophrenia more susceptible to being influenced during pandemic situations? A glimpse provided by the COVID-19 pandemic
- Striatum and globus pallidus structural abnormalities in schizophrenia: A retrospective study of the different stages of the disease
- The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review
- Multimorbidity and the Etiology of Schizophrenia
- The psychopathology among the offspring of schizophrenia and bipolar I disorder patients in an Egyptian sample: A comparative study
- Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia
- Functional recovery in older adults with schizophrenia: A national interRAI study
- Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study
- Visual salience is affected in participants with schizophrenia during free-viewing
- Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis
- Prevalence and risk factors of suicide attempts among Chinese elderly patients over 50 years with schizophrenia
- Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)
- Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders
- Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders
- Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients
- "People don't have the answers": A qualitative exploration of the experiences of young people with Long COVID
- Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders
- Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Research progress in mitochondrial quality control in schizophrenia
- EXPRESS: Emotional anticipation for dynamic emotional faces is not modulated by schizotypal traits: A Representational Momentum study
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- 18q Deletion Syndrome-Associated Schizophrenia: A Case Report
- 18q Deletion Syndrome-Associated Schizophrenia: A Case Report
- Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia
- Delusions and Delinquencies: A Comparison of Violent and Non-Violent Offenders With Schizophrenia Spectrum Disorders
- Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin
- Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and…
Evidence Blueprint
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
🌐 365 Days
VR Related Evidence Matrix
- A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia
- Making meaning of multimorbidity and severe mental illness: A viewpoint
- A challenge to the dopamine orthodoxy in schizophrenia?
- Clozapine-induced eosinophilia: A case report
- Letter to the Editor: Letter to the Editor regarding 'A challenge to the dopamine orthodoxy in schizophrenia'
- Letter to the Editor: Letter to the Editor regarding 'A challenge to the dopamine orthodoxy in schizophrenia?'
- HIV Viral Suppression Among Psychiatric Inpatients with Schizophrenia in San Francisco: A Retrospective Cohort Study
- Physical health monitoring for people with schizophrenia
- What are the autism research priorities of autistic adults in Scotland?
- Schizophrenia: from neurochemistry to circuits, symptoms and treatments
- P300 in Schizophrenia: Then and Now
- A lifetime of mental health treatments for people with schizophrenia: update and narrative review
- The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Prevalence and Correlates Of Sexual Dysfunction Among Patients With Schizophrenia Spectrum Disorder on Antipsyhotic Medications in Maiduguri, Northeastern Nigeria
- Migraine in bipolar disorder and schizophrenia; The hidden pain
- Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice
- The contribution of first-episode illness characteristics and cumulative antipsychotic usage to progressive structural brain changes over a long-term follow-up in schizophrenia
- Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
- Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades
- Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial
- Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study
- A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
- Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia
- Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
- Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019
- Research Letter: Perceived rather than actual reduction in standard of living is associated with psychological distress: A cross-sectional survey of working Australians
- The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial
- Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
- Psychotic Experiences and Daily Functioning in Borderline Personality Disorder and Schizophrenia
- Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
- D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up
- Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community
- Schizophrenia in Autistic People with Intellectual Disabilities. Treatment and Interventions
- Supports that help me to live well in the community: experiences of people living with schizophrenia
- Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective
- Luxenburger's 1939 Essay on "Schizophrenia and its Hereditary Circle"
- Empathy in the Care of Individuals With Schizophrenia: A Vital Element of Treatment
- The association of lower urinary tract symptoms with schizophrenia and its treatments: A narrative review
- Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report
- The effect of vortioxetine on anhedonia in patients with schizophrenia
- Estrogen and psychosis - a review and future directions
- An international research agenda for clozapine-resistant schizophrenia
- Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia
- A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
- Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
- Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia
- Career progression for autistic people: A scoping review
- Orphan GPR52 as an emerging neurotherapeutic target
- Cross-sectional study on the dissociation of decision-making capacity for antipsychotic treatment and COVID-19 vaccination in individuals with schizophrenia
- The Associative Thalamus: A Switchboard for Cortical Operations and a Promising Target for Schizophrenia
- Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study
- The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
- Depression in caregivers of patients with schizophrenia: a scoping review
- Hypersexuality during treatment with cariprazine in a patient with schizophrenia? A case report
- Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study
- Expert Comment: Three factors that help beat the odds in Young Lives
- Examining the Impact of State-Level Factors on HIV Testing for Medicaid Enrollees with Schizophrenia
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study
- Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?
- Antipsychotic medication non-adherence and factors associated among patients with schizophrenia in eastern Ethiopia
- Implementation of cognitive rehabilitation interventions for schizophrenia in low-income countries: An experience from Togo and Benin
- Disorganized Communication and Social Dysfunction in Schizophrenia: Emerging Concepts and Methods